NeuroTransData, Neuburg an der Donau, Germany.
Roche Pharma AG, Grenzach-Wyhlen, Germany.
BMC Neurol. 2023 Jul 5;23(1):258. doi: 10.1186/s12883-023-03273-9.
Primary progressive multiple sclerosis (PPMS) is characterised by gradual worsening of disability from symptom onset. Knowledge about the natural course of PPMS remains limited.
PPMS patients from the German NeuroTransData (NTD) MS registry with data from 56 outpatient practices were employed for retrospective cross-sectional and longitudinal analyses. The cross-sectional analysis included a contemporary PPMS cohort with a documented visit within the last 2 years before index date (1 Jan 2021). The longitudinal analysis included a disease modifying therapy (DMT)-naïve population and focused on the evolution of expanded disability status scale (EDSS) from the first available assessment at or after diagnosis within the NTD registry to index date. Outcome measures were estimated median time from first EDSS assessment to first 24-week confirmed EDSS ≥ 4 and ≥ 7. Besides EDSS change, the proportion of patients on disability pension were described over time.
The cross-sectional analysis included 481 PPMS patients (59.9% female, mean [standard deviation, SD] age 60.5 [11.5] years, mean [SD] EDSS 4.9 [2.1]). Estimated median time from first EDSS assessment after diagnosis to reach 24-week confirmed EDSS ≥ 4 for DMT-naïve patients was 6.9 years. Median time to EDSS ≥ 7 was 9.7 years for 25% of the population. Over a decade mean (SD) EDSS scores increased from 4.6 (2.1) to 5.7 (2.0); the proportion of patients on disability pension increased from 18.9% to 33.3%.
This study provides first insights into the German NTD real-world cohort of PPMS patients. Findings confirm the steadily deteriorating course of PPMS accompanied by increasingly limited quality of life.
原发性进行性多发性硬化症(PPMS)的特点是从症状发作开始,残疾逐渐恶化。关于 PPMS 的自然病程的知识仍然有限。
采用德国神经转译数据(NTD)多发性硬化症登记处的数据,对来自 56 家门诊的 PPMS 患者进行回顾性横断面和纵向分析。横断面分析包括最近 2 年内记录的有就诊记录的当代 PPMS 队列,其就诊日期为索引日期(2021 年 1 月 1 日)之前。纵向分析包括一个未经疾病修正治疗(DMT)的人群,重点是从 NTD 登记处首次可用的评估到索引日期的扩展残疾状态量表(EDSS)的演变。结局测量为从首次 EDSS 评估到首次 24 周 EDSS≥4 和≥7 的中位时间。除 EDSS 变化外,还描述了随着时间的推移,残疾抚恤金患者的比例。
横断面分析包括 481 名 PPMS 患者(59.9%为女性,平均[标准差,SD]年龄为 60.5[11.5]岁,平均[SD]EDSS 为 4.9[2.1])。DMT 初治患者从首次 EDSS 评估到达到 24 周 EDSS≥4 的中位时间为 6.9 年。中位数时间为 9.7 年,达到人群的 25%。在 10 年内,平均(SD)EDSS 评分从 4.6(2.1)增加到 5.7(2.0);残疾抚恤金患者的比例从 18.9%增加到 33.3%。
本研究首次深入了解了德国 NTD 的 PPMS 患者真实世界队列。结果证实,PPMS 的病情不断恶化,生活质量日益受限。